Decisions Home

United States Blood Group Market Insight

Published: 15 June 2026   |   Report Format: Electronic (PDF)

The United States Blood Group Market is projected to grow at a CAGR of 7.2%, driven by increasing blood donation activities, rising surgical procedures, expanding transfusion requirements, advancements in immunohematology diagnostics, and growing adoption of automated blood grouping technologies across healthcare settings.

United States Blood Group Market Forecasts to 2035

  • The United States Blood Group Market Size was Estimated at USD 1.86 Billion in 2025.
  • The Market Size is Expected to Grow at a CAGR of around 7.2% from 2025 to 2035.
  • The United States Blood Group Market Size is Expected to Reach around USD 3.73 Billion by 2035.

Notable Insights in the United States Blood Group Market

  • Segmentation Based on Product Type, the Reagents & Kits segment held a dominant position in the United States Blood Group Market in 2025 with nearly 61.8% share, supported by their routine utilization in blood typing, compatibility testing, and donor screening procedures.
  • Segmentation Based on End User, the Hospitals segment accounted for approximately 46.5% share in 2025, driven by increasing inpatient admissions, trauma cases, transplant procedures, and expanding transfusion services.
  • The United States Blood Group Market is led by Danaher Corporation, Bio-Rad Laboratories, Inc., and Abbott Laboratories, with combined revenues of approximately USD 57.29 billion in 2025, reflecting their leadership in transfusion diagnostics and immunohematology solutions.

Download the eBook (ToC)

We value your privacy.

 

What Makes Decisions Advisors Research Unique?

Decisions Advisors offers intelligent market research which includes advanced analysis of infrared sensor technologies, optoelectronic semiconductors, AI-driven sensing solutions, and remote sensing. Our research identifies potential areas of business development, technology adoption rates, competitive position analysis, and important strategic changes in South Korea Remote Sensing Infrared Light Emitting Diode Market.

 

The research process uses advanced methodologies such as primary research interview approaches, industry research, tracking the semiconductor value chain, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology forecasting. The study examines the demand for semiconductor solutions in automotive electronics, industrial automation, health care monitoring, and smart surveillance applications in South Korea.

 

In-depth analysis of key infrared LED players, optoelectronic semiconductor innovations, AI-enabled sensing solutions, product launch activities, and collaborations is included in the report. The report also covers semiconductor regulations, technology research and development analysis, smart sensor infrastructure, and new opportunities available in the South Korea Remote Sensing Infrared Light Emitting Diode Market.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States blood group market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Companies in the United States Blood Group Market

 

Recent Developments:

 

Market Segmentation:

United States Blood Group Market, By Product Type

United States Blood Group Market, By Test Type

United States Blood Group Market, By Technology

United States Blood Group Market, By End User

 

Expert Views:

The United States Blood Group Market is anticipated to witness substantial growth through 2035, supported by increasing transfusion demands, expanding automation adoption, and advancements in immunohematology diagnostics. Product innovations and strategic collaborations among key players are expected to intensify competition and improve diagnostic efficiency across healthcare institutions.


Author: Govind and Krishna By Decisions Advisors and Consulting